Verbatim response from ChatGPT
Short answer: Mostly no — most “compounded GLP‑1 drops/tablets” sold online or by some compounding pharmacies are unlikely to work reliably and carry safety risks. The only reliably effective oral GLP‑1 is an FDA‑approved formulation (Rybelsus®), and most of the best‑proven GLP‑1/GLP‑1‑GIP drugs are injections.
Why compounded oral GLP‑1s are unreliable
- GLP‑1 drugs are peptides that are normally broken down in the stomach and gut. Making them bioavailable by mouth requires special formulation/chemical technology — not just putting the peptide into a dropper bottle or tablet.
- Rybelsus (oral semaglutide) is effective because it uses a proprietary absorption enhancer (SNAC) and was tested in clinical trials. Simple compounding cannot reproduce that mechanism or the controlled, validated dosing.
- Compounded products often have big variability in dose, stability, and purity, and they aren’t FDA‑approved or supported by large clinical trials. That raises safety (contamination, incorrect dosing) and efficacy concerns.
What works and what’s approved
- Oral: Rybelsus® (semaglutide) — FDA‑approved for type 2 diabetes. It has demonstrated efficacy but generally gives less weight loss than injectable semaglutide at the doses used for obesity and must be taken exactly as directed (empty stomach, small sip of water, wait ~30 minutes before eating).
- Injectables (better‑proven for weight loss and diabetes): Ozempic® (semaglutide, diabetes), Wegovy® (semaglutide 2.4 mg for obesity), Mounjaro® (tirzepatide for diabetes), Zepbound® (tirzepatide for obesity), Trulicity® (dulaglutide), Victoza® (liraglutide). These have consistent absorption and the strongest evidence for weight loss and metabolic effects.
- No FDA‑approved compounded GLP‑1 drops/tablets for diabetes or weight loss exist.
Safety and practical points
- Compounded “drops” are popular on social media because they may be cheaper or easier to take, but there have been regulatory and safety warnings about unapproved compounded peptides.
- Inaccurate dosing can lead to side effects (severe nausea, vomiting, dehydration, hypoglycemia in people on other diabetes meds) or lack of effect.
- If cost is the issue, manufacturers and pharmacies often have patient assistance programs, coupons, or you can discuss alternatives with your clinician.
What I recommend
- Avoid unapproved compounded GLP‑1 drops/tablets. They’re unlikely to reliably work and carry safety risks.
- If you prefer oral, ask your clinician about Rybelsus® (approved oral semaglutide) and whether it’s appropriate for you.
- If your goal is weight loss or the greatest metabolic benefit, discuss injectable options (Wegovy, Mounjaro, Ozempic, etc.) with a clinician experienced in GLP‑1 therapy.
- Always get GLP‑1 therapy through a licensed prescriber and a reputable pharmacy, and report side effects promptly.
If you want, tell me your goal (type 2 diabetes control vs weight loss) and any medications or medical problems you have, and I can outline which approved options would be reasonable to discuss with your provider.